Goldman Sachs’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.62M Sell
1,605,325
-275,290
-15% -$2.07M ﹤0.01% 3105
2025
Q4
$13.5M Buy
1,880,615
+223,953
+14% +$1.77M ﹤0.01% 2773
2025
Q3
$17.7M Sell
1,656,662
-230,029
-12% -$2.26M ﹤0.01% 2379
2025
Q2
$18.3M Buy
1,886,691
+451,493
+31% +$4.66M ﹤0.01% 2205
2025
Q1
$21.4M Buy
1,435,198
+801,307
+126% +$12.3M ﹤0.01% 1970
2024
Q4
$9.46M Buy
633,891
+19,400
+3% +$316K ﹤0.01% 2851
2024
Q3
$11.8M Sell
614,491
-300,562
-33% -$6.23M ﹤0.01% 2557
2024
Q2
$18.9M Buy
915,053
+363,630
+66% +$7.23M ﹤0.01% 1934
2024
Q1
$10.4M Buy
551,423
+131,666
+31% +$2.26M ﹤0.01% 2437
2023
Q4
$6.05M Sell
419,757
-1,088,678
-72% -$14.8M ﹤0.01% 3000
2023
Q3
$26.2M Sell
1,508,435
-682,048
-31% -$14.2M 0.01% 1575
2023
Q2
$45.6M Buy
2,190,483
+1,453,728
+197% +$31.6M 0.01% 1177
2023
Q1
$17.3M Buy
736,755
+371,567
+102% +$9.98M ﹤0.01% 1944
2022
Q4
$10.2M Sell
365,188
-231,313
-39% -$5.91M ﹤0.01% 2568
2022
Q3
$14M Buy
596,501
+66,299
+13% +$2M ﹤0.01% 2187
2022
Q2
$17.9M Sell
530,202
-636,522
-55% -$22.3M ﹤0.01% 1986
2022
Q1
$40.8M Buy
1,166,724
+408,618
+54% +$14M 0.01% 1453
2021
Q4
$23.1M Sell
758,106
-518,838
-41% -$16.9M ﹤0.01% 1986
2021
Q3
$41.9M Buy
1,276,944
+31,495
+3% +$1.01M 0.01% 1413
2021
Q2
$37.7M Buy
+1,245,449
New +$41M 0.01% 1509

Other funds holding OGN

Goldman Sachs's OGN Position: Q1 2026 in Review

Goldman Sachs reduced its Organon & Co (OGN) stake by 15% in Q1 2026, selling an estimated $2.07M and leaving 1,605,325 shares worth $9.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3105.

Goldman Sachs first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $45.6M in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Goldman Sachs held 1,605,325 shares of Organon & Co worth $9.62M as of Q1 2026.
  • Goldman Sachs sold 275,290 Organon & Co shares in Q1 2026, an estimated $2.07M.
  • Organon & Co made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3105 holding.
  • Goldman Sachs first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Goldman Sachs's Organon & Co position peaked at $45.6M in Q2 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.